Company Filing History:
Years Active: 2022-2025
Title: The Innovative Contributions of Clinton Weber
Introduction
Clinton Weber is a prominent inventor based in Seattle, WA (US), known for his significant contributions to the field of cell therapy. With a total of 4 patents, he has made strides in developing methods for genetically engineering T cells, which are crucial for therapeutic applications.
Latest Patents
One of Clinton Weber's latest patents is titled "Process for generating therapeutic compositions of engineered cells." This patent outlines methods for genetically engineering T cells, such as CD4+ T cells, for use in cell therapy. The methods include steps for incubating the cells under stimulating conditions, introducing a recombinant polypeptide through transduction or transfection, and cultivating the cells to promote proliferation and expansion. The efficiency and reliability of these methods provide a high degree of success in producing genetically engineered T cells.
Another notable patent is "Determining toxicity risk in CAR T-cell therapy." This patent presents methods, compositions, and articles of manufacture for cell therapy involving therapeutic T cell compositions. The T cells express recombinant receptors, including chimeric antigen receptors (CARs) and other transgenic receptors. The features of this invention offer advantages such as a lower risk of toxicity for subjects receiving the T cell compositions.
Career Highlights
Clinton Weber is currently associated with Juno Therapeutics GmbH, where he continues to advance his research and innovations in cell therapy. His work has been instrumental in enhancing the safety and efficacy of T cell therapies, which are vital for treating various diseases.
Collaborations
Clinton has collaborated with notable colleagues, including Christopher Glen Ramsborg and Brian Christin, contributing to a dynamic research environment that fosters innovation and development in the field of cell therapy.
Conclusion
Clinton Weber's innovative work in the field of cell therapy, particularly in the engineering of T cells, showcases his commitment to advancing medical science. His patents reflect a deep understanding of the complexities involved in therapeutic applications, making him a valuable contributor to the industry.